• Grant accepted


OncoMax is a private biotechnology company founded in 2010 with the goal of developing and launching new diagnostic and therapeutic anti-cancer agents. The company is a participant of Technology Platform “Medicine of the Future” and a Skolkovo resident awarded with a Skolkovo Foundation grant. In early 2012 OncoMax has been awarded as the best deal of year 2011 in “venture and direct investment” nomination of Russian Investor Award.